Physician
Yong Kang Medical PLLC
Yong Kang Medical PLLC was paid $4.75M by Medicaid between Jan 2018 and Oct 2024, across 100 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 49% of everything it billed.
33Billing provider infoYONG KANG MEDICAL PLLC
BROOKLYN, NY 11220
BROOKLYN, NY 11220
33aNPI1972803328assigned 11/01/2010
33bProvider typeFamily Medicine Physician
28Total paid$4.75M
24GClaims122,020
24DCodes billed100
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#35 of 2,605
Median peer was paid$10K
This provider vs. median471×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,725 | $863K | |
| 2019 | 29,795 | $1.01M | |
| 2020 | 23,732 | $826K | |
| 2021 | 44,463 | $1.89M | |
| 2022 | 1,568 | $89K | |
| 2023 | 840 | $32K | |
| 2024incomplete | 897 | $43K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 49% | 28,995 | 22,640 | $2.32M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 15% | 14,712 | 12,129 | $724K |
| 99442 | 7.4% | 5,397 | 4,861 | $350K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 6.9% | 2,610 | 2,600 | $329K |
| 99443 | 4.3% | 2,272 | 2,164 | $202K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.0% | 1,233 | 1,232 | $144K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.9% | 1,145 | 1,058 | $140K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1.1% | 5,474 | 5,461 | $55K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 3,425 | 3,338 | $54K |
| 90756 | 1.1% | 1,909 | 1,906 | $50K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.0% | 2,606 | 2,342 | $50K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.0% | 438 | 435 | $49K |
88 more codes
| 83013 | <1% | 1,021 | $44K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 3,121 | $44K |
| 93000 | <1% | 3,682 | $36K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 286 | $29K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 186 | $20K |
| 86769 | <1% | 824 | $18K | |
| 0013A | <1% | 250 | $10K | |
| 94010 | <1% | 296 | $8K | |
| 90686 | <1% | 1,317 | $7K | |
| 92551 | <1% | 754 | $6K | |
| 81001 | <1% | 3,291 | $5K | |
| 83014 | <1% | 819 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,170 | $4K |
| 90674 | <1% | 133 | $4K | |
| 36410 | <1% | 624 | $4K | |
| 90688 | <1% | 190 | $4K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 47 | $3K |
| 0011A | <1% | 80 | $3K | |
| 0012A | <1% | 74 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 73 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 30 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 47 | $2K |
| 90746 | <1% | 24 | $2K | |
| 80061 | Lipid panel | <1% | 237 | $2K |
| 86580 | <1% | 211 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 194 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 136 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 13 | $1K |
| 90651 | <1% | 42 | $1K | |
| 99173 | <1% | 543 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 52 | $1K |
| H0001 | Alcohol and/or drug assessment | <1% | 3,441 | $894.36 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 28 | $794.55 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 33 | $751.08 |
| 0072A | <1% | 20 | $736.92 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 197 | $678.18 |
| 96127 | <1% | 210 | $631.47 | |
| 99051 | <1% | 86 | $601.62 | |
| 80053 | Comprehensive metabolic panel | <1% | 70 | $480.20 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 57 | $447.72 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 18 | $435.55 |
| 86708 | <1% | 53 | $426.65 | |
| 86704 | <1% | 50 | $392.00 | |
| 82274 | <1% | 43 | $388.68 | |
| 86706 | <1% | 54 | $376.92 | |
| 81003 | <1% | 384 | $375.78 | |
| 86709 | <1% | 51 | $373.32 | |
| 87340 | <1% | 54 | $362.88 | |
| 83540 | <1% | 71 | $298.20 | |
| 83615 | <1% | 71 | $279.03 | |
| 84481 | <1% | 24 | $264.24 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 69 | $262.60 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 24 | $246.66 |
| 84432 | <1% | 23 | $240.12 | |
| 88142 | <1% | 45 | $225.87 | |
| 84100 | <1% | 71 | $218.68 | |
| 84550 | <1% | 72 | $211.68 | |
| 84439 | <1% | 30 | $175.80 | |
| 81000 | <1% | 65 | $172.26 | |
| 99406 | <1% | 139 | $156.71 | |
| 84480 | <1% | 23 | $138.30 | |
| 84436 | <1% | 23 | $102.58 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 162 | $90.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12 | $64.13 |
| 83721 | <1% | 74 | $61.38 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | <1% | 3,360 | $40.00 |
| 99000 | <1% | 8,745 | $24.56 | |
| G9275 | Documentation that patient is a current non-tobacco user | <1% | 3,590 | $24.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 2,907 | $24.00 |
| S0612 | Annual gynecological examination, established patient | <1% | 48 | $20.00 |
| 3049F | <1% | 12 | $18.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 792 | $12.00 |
| 90461 | <1% | 95 | $11.46 | |
| 91301 | <1% | 185 | $7.33 | |
| 3008F | <1% | 181 | $0.43 | |
| 3725F | 0% | 369 | $0.00 | |
| G9276 | Documentation that patient is a current tobacco user | 0% | 160 | $0.00 |
| 3016F | 0% | 161 | $0.00 | |
| 82465 | 0% | 47 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 55 | $0.00 |
| 90672 | 0% | 31 | $0.00 | |
| 83718 | 0% | 47 | $0.00 | |
| 4293F | 0% | 249 | $0.00 | |
| 1000F | 0% | 326 | $0.00 | |
| 1036F | 0% | 262 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 494 | $0.00 |
| 84478 | 0% | 47 | $0.00 | |
| 91307 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHE, YONG KANG (INTERNAL MEDICINE)
| Provider | Location | Paid |
|---|---|---|
| Four Season Medical PLLC | Brooklyn, NY | $11.51M |
| Juniper Medicine PLLC | Brooklyn, NY | $879K |
| Well Wellness Medical PLLC | Brooklyn, NY | $828.72 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.